Lazard Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,100
| Closed | -$6K | – | 2474 |
|
|
2025
Q1 | $6K | Sell |
2,100
-395
| -16% | -$1.13K | ﹤0.01% | 2176 |
|
|
2024
Q4 | $7K | Buy |
2,495
+2,005
| +409% | +$5.63K | ﹤0.01% | 2118 |
|
|
2024
Q3 | $1K | Sell |
490
-107,413
| -100% | -$219K | ﹤0.01% | 2189 |
|
|
2024
Q2 | $351K | Buy |
107,903
+58,437
| +118% | +$190K | ﹤0.01% | 1347 |
|
|
2024
Q1 | $262K | Buy |
49,466
+48,520
| +5,129% | +$257K | ﹤0.01% | 1217 |
|
|
2023
Q4 | $4K | Buy |
+946
| New | +$4K | ﹤0.01% | 2132 |
|
|
2021
Q3 | – | Sell |
-6,984
| Closed | -$64K | – | 2256 |
|
|
2021
Q2 | $64K | Buy |
+6,984
| New | +$64K | ﹤0.01% | 1501 |
|